How much funding has Orbital Therapeutics raised?

Orbital Therapeutics has raised $270.0M in total funding, most recently a Series A round.

Who are Orbital Therapeutics's investors?

Orbital Therapeutics's investors include ARCH Venture Partners, Andreessen Horowitz.

When was Orbital Therapeutics founded?

Orbital Therapeutics was founded in 2022.

Where is Orbital Therapeutics headquartered?

Orbital Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Orbital Therapeutics in?

Orbital Therapeutics operates in Healthcare.

How many employees does Orbital Therapeutics have?

Orbital Therapeutics has 51-200 employees.

Orbital Therapeutics

RNA medicines built around disease biology

Cambridge, United States · Founded 2022 · $270.0M raised

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2022
Business Model: B2B

Website: orbitaltx.com
Total Funding: $270.0M
Last Round: $270.0M Series AApr 2023
Rounds: 1

About

Orbital Therapeutics is advancing a new generation of RNA medicines designed to reprogram cells in vivo, treating diseases at their source. Using a comprehensive set of RNA tools and technologies, the company creates therapies with precision and flexibility to address the underlying biology of immune-driven diseases. Orbital was acquired by Bristol Myers Squibb in October 2025 for $1.5 billion.

Summary

Orbital Therapeutics is a Healthcare company based in Cambridge, United States, founded in 2022. It has raised $270.0M in total across 1 round, most recently a $270.0M Series A round in Apr 2023. Investors include ARCH Venture Partners and Andreessen Horowitz.